Multidisciplinary Cutaneous Lymphoma Group

Leadership and Excellence
in Patient Care and Research

MCLC Group 2014

 

Mission

To provide excellence in patient care and leadership in scientific investigation of cutaneous lymphomas that will lead to greater knowledge and the development of new therapies to improve the survival and the quality of life of our patients.

The Stanford Multidsciplinary Cutaneous Lymphoma team offers expert treatment for patients with cutaneous lymphomas, including mycosis fungoides, Sezary syndrome,
CD30+ lymphoproliferative disorders (lymphomatoid papulosis and anaplastic large cell lymphoma), subcutaneous panniculitis-like T-cell lymphoma, gamma-delta T-cell lymphoma, CD8+ aggressive epidermotropic T-cell lymphoma, NK/T-cell lymphoma, other unspecified cutaneous peripheral T-cell lymphomas, and cutaneous B-cell lymphomas. Our physicians subspecialize in treating these types of cancers, and have extensive expertise in handling the most complicated cases. Care among specialists is tightly integrated.

Read more about the Stanford Cutaneous Lymphoma Program 2013 (pdf) More>>

 

What's New

 

Make a gift to the Cutaneous Lymphoma Research Fund

 

"What's New" news and alerts archive.

Stanford Medicine Resources:

Footer Links: